How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

800 results for

Lidocaine Patch

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Trends in patch-test results and allergen changes in the standard series: A Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). (Abstract)

-nitropropane-1,3-diol, 0.25%; and lidocaine, 5%. Many final patch-test readings for many allergens were categorized as mild reactions (erythema only). Overall allergenicity and irritancy rates declined significantly since our prior report. Results were generally comparable with those in a North American Contact Dermatitis Group report from 2005 to 2006.This was a retrospective study; there is a lack of long-term follow-up.Since our previous report, our standard series composition has changed, and overall (...) Trends in patch-test results and allergen changes in the standard series: A Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010). Patch testing is essential for identification of culprits causing allergic contact dermatitis.We sought to identify trends and allergen changes in our standard series during 2006 to 2010, compared with our previous report (2001-2005).We conducted a retrospective review of patch-test results.A total of 3115 patients were tested with a mean

2013 Journal of American Academy of Dermatology

102. Lidocaine

website in a new browser window. Related Studies (from Trip Database) Cost: Medications lidocaine (on 5/17/2017 at ) LIDOCAINE 2% VISCOUS SOLN Generic $0.07 per ml LIDOCAINE 3% CREAM Generic $1.26 per gram LIDOCAINE 4% CREAM Generic OTC $0.91 per gram LIDOCAINE 5% OINTMENT Generic $1.37 per gram LIDOCAINE 5% PATCH Generic $3.04 each LIDOCAINE ANORECTAL 5% CREAM Generic OTC $1.28 per gram LIDOCAINE HCL 1% VIAL Generic $0.06 per ml LIDOCAINE HCL 2% JELLY Generic $0.82 per ml LIDOCAINE HCL 2% VIAL (...) Lidocaine Lidocaine Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Lidocaine Lidocaine Aka: Lidocaine From Related Chapters II

2015 FP Notebook

103. Use of lidocaine patch for percutaneous endoscopic lumbar discectomy. Full Text available with Trip Pro

Use of lidocaine patch for percutaneous endoscopic lumbar discectomy. Lidocaine patch (L5P) has demonstrated short-term efficacy in treating both acute surgical pain and chronic neuropathic pain with tolerable side effects. Percutaneous endoscopic lumbar discectomy (PELD) is the mainstay of minimally invasive spine surgery (MISS). Sufficient analgesia during PELD surgery makes the patient consider it real MISS. This study was performed to evaluate the efficacy and adverse effects of lidocaine (...) patch in patients who underwent PELD under local anesthesia.L5P (L group) or placebo (P group) was randomly applied on the skin of the back covering the anticipated path of the working channel before 1 hour of surgery in 100 patients who underwent a single level PELD at L4-L5. Efficacy of the lidocaine patch was assessed by patient's numeric rating scale (NRS) of pain at each stage during the surgery and by a 5-scale grading of the satisfaction with the anesthesia of the operator and patients after

2011 The Korean journal of pain Controlled trial quality: uncertain

104. Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy

Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Lidocaine Patch for Postoperative Analgesia After Laparoscopic Cholecystectomy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01485939 Recruitment Status : Unknown Verified December 2011 by Seoul National University Hospital. Recruitment status was: Recruiting First Posted : December 6, 2011 Last Update

2011 Clinical Trials

105. Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients

Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01307839 Recruitment Status : Withdrawn (Study was stopped due to non-availability of the lidocaine placebo patches.) First Posted : March 3, 2011 Last Update

2011 Clinical Trials

106. Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain

Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01443325 Recruitment Status : Completed First Posted : September 29, 2011 Last Update Posted : June 22, 2012 Sponsor: Rigshospitalet, Denmark Information provided by (Responsible

2011 Clinical Trials

107. Prevalence of benzocaine and lidocaine patch test sensitivity in Denmark: temporal trends and relevance. Full Text available with Trip Pro

Prevalence of benzocaine and lidocaine patch test sensitivity in Denmark: temporal trends and relevance. BACKGROUND. Allergens included in the European baseline series should result in positive patch test reactions in at least 1% of a patch test population. Inclusion of local anaesthetics other than benzocaine in the baseline series has previously been debated.To investigate temporal trends of benzocaine and lidocaine allergy in dermatitis patients who underwent routine patch testing (...) in a tertiary referral patch test centre, and to clarify and discuss whether lidocaine and benzocaine should be included in routine series.Dermatitis patients who underwent routine patch testing with benzocaine as a part of the European baseline series between 1985 and 2010 (n = 19 347) and dermatitis patients who underwent routine patch testing with lidocaine between 1994 and 2001 (n = 6265) and between 2007 and 2009 (n = 1360) were included.The overall prevalences of contact allergy were 0.5% (benzocaine

2011 Contact Dermatitis

108. Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial. (Abstract)

Effects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trial. This study evaluated the effects of topical lidocaine on skin sensation and on intradermal capsaicin-induced pain and hyperalgesia. A randomized, double-blinded, placebo controlled methodology was used. After baseline sensory testing, a placebo patch and a lidocaine patch were randomized to the volar aspect of the left or right forearm for 4 hours. The right forearm patch was removed, the sensory (...) sensation, warm sensation, and touch thresholds in the lidocaine but not placebo patch arm. The lidocaine patch had no significant effect on hot pain or mechanical pain thresholds. Intradermal capsaicin resulted in a significant decrease in hot pain and mechanical pain thresholds; however, lidocaine was unable to significantly reverse the thermal or mechanical hyperalgesia induced by capsaicin. The lidocaine patch did not reduce flare area, nor areas of hyperalgesia or allodynia. This study suggests

2011 The journal of pain : official journal of the American Pain Society Controlled trial quality: predicted high

109. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin. (Abstract)

Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin. Topical application of lidocaine is an effective approach for treatment of post-herpetic neuralgia and other painful neuropathies. Lidocaine inhibits voltage-gated Na(+) channels and it most likely reduces excitability of cutaneous sensory neurons which can be hyperexcitable or spontaneously active in states of neuropathic pain. However (...) , lidocaine and other local anesthetics also exert a pronounced neurotoxicity and they activate the irritant receptors TRPV1 and TRPA1. In this randomized and double-blinded study, we explored the ability of lidocaine patches (5%) to alter sensory function and epidermal nerve fiber density in skin of healthy volunteers. As assessed by quantitative sensory testing, significantly elevated thresholds for touch, pin prick pain and mechanically induced wind-up were observed in skin treated with lidocaine

2011 European Journal of Pain Controlled trial quality: uncertain

110. Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia. Full Text available with Trip Pro

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia. Post-herpetic neuralgia (PHN) is a common type of neuropathic pain that can severely affect quality of life. NGX-4010, a capsaicin 8% dermal patch, is a localized treatment that can provide patients with significant pain relief for up to 3 months following a single 60-minute application. The NGX-4010 application can be associated (...) with application-site pain and in previous clinical trials pretreatment with a topical 4% lidocaine anesthetic was used to enhance tolerability. The aim of the current investigation was to evaluate tolerability of NGX-4010 after pretreatment with lidocaine 2.5%/prilocaine 2.5% anesthetic cream.Twenty-four patients with PHN were pretreated with lidocaine 2.5%/prilocaine 2.5% cream for 60 minutes before receiving a single 60-minute application of NGX-4010. Tolerability was assessed by measuring patch application

2011 BMC Anesthesiology

111. Study of Use of Synera for Pain During Local Skin Infiltration With Lidocaine Before Epidural Placement

, 2013 Last Update Posted : May 14, 2015 Sponsor: Northwell Health Information provided by (Responsible Party): Northwell Health Study Details Study Description Go to Brief Summary: Local infiltration with lidocaine prior to epidural placement for cesarean section, although brief, can be painful. This pain can lead to increased anxiety and distress, adversely affecting patient's overall experience. This study proposes to examine the application of Synera pain patch prior to lidocaine infiltration (...) to reduce this pain and anxiety. The primary objective of this study is to determine the effect of the Synera on maternal experience during epidural placement. The efficacy of Synera pain patch in reducing subject pain during skin infiltration with lidocaine prior to epidural placement in subjects presenting for scheduled cesarean section will be assessed. Condition or disease Intervention/treatment Phase Pain Anxiety Drug: Synera Phase 4 Study Design Go to Layout table for study information Study Type

2012 Clinical Trials

112. Is there any evidence that versatis (5% lidocaine patch) has any effect in non-herpetic neuropathic pain?

Is there any evidence that versatis (5% lidocaine patch) has any effect in non-herpetic neuropathic pain? Is there any evidence that versatis (5% lidocaine patch) has any effect in non-herpetic neuropathic pain? - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere (...) clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any evidence that versatis (5% lidocaine patch) has any effect in non-herpetic neuropathic pain? CKS guidance entitled neuropathic pain- prescribing information for adjunct

2010 TRIP Answers

113. Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow

Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01525043 Recruitment Status : Completed First Posted : February 2, 2012 Last

2012 Clinical Trials

114. In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction?

of Texas Health Science Center, Houston. Recruitment status was: Recruiting First Posted : April 12, 2012 Last Update Posted : April 12, 2012 Sponsor: The University of Texas Health Science Center, Houston Collaborator: ZARS Pharma Inc. Information provided by (Responsible Party): Samia Khalil, The University of Texas Health Science Center, Houston Study Details Study Description Go to Brief Summary: The purpose of this study is to evaluate if the Synera Patch (lidocaine/tetracaine patch), used to numb (...) the skin before IV placement, is effective in reducing pain associated with propofol IV administration when inducing general anesthesia, compared to Gebauer's Ethyl Chloride topical anesthetic skin refrigerant. Condition or disease Intervention/treatment Phase Pain on Propofol IV Injection Device: lidocaine/tetracaine transdermal patch (NDC 43469-864-01) Drug: Gebauer's Ethyl Chloride Phase 4 Detailed Description: Commonly, anesthesiologists inject Propofol, a sleeping medication, intravenously

2012 Clinical Trials

115. Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

by (Responsible Party): MEDRx USA, Inc. Study Details Study Description Go to Brief Summary: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of the Shoulder. Condition or disease Intervention/treatment Phase Bursitis Tendonitis Shoulder Pain Drug: MRX-7EAT Phase 3 (...) to a nerve entrapment syndrome or other medical problem that in the investigator's opinion may interfere with pain measurement of the target joint. Subject has active skin lesions or disease at the intended site of study medication application, which may be covered by the patch. Skin lesions include open wounds, rash, papules and vesicles; abrasions, lacerations or any break in skin. Subject has a history of allergy to etodolac, other NSAIDs, lidocaine or adhesives (e.g., adhesive tape). Subject

2012 Clinical Trials

116. Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome

: Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch Drug: Triamcinolone Acetonide Phase 2 Detailed Description: Subjects will receive either a subacromial injection at baseline or will be issued Synera patches to use daily for 2 weeks and then PRN for an additional 2 weeks. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 60 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open (...) Label) Primary Purpose: Treatment Official Title: Heated Lidocaine Patch Compared to Subacromial Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome, A Pilot Study Start Date : March 2012 Estimated Primary Completion Date : January 2014 Estimated Study Completion Date : March 2014 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Patch Patch will be applied directly

2012 Clinical Trials

117. A comparison of Rapydan® patch and Ametop® gel for venous cannulation. (Abstract)

A comparison of Rapydan® patch and Ametop® gel for venous cannulation. Ametop(®) gel (4% tetracaine) is used to provide topical anaesthesia for venous cannulation. Rapydan(®) patch (7% lidocaine and 7% tetracaine) has been developed to provide topical anaesthesia by a different mechanism, that of heat assisted delivery. We compared the topical anaesthetic effect of these agents for venous cannulation. One hundred healthy adults undergoing day-case surgery were randomly assigned to receive

2012 Anaesthesia Controlled trial quality: uncertain

118. Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis

Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis - Full Text View - ClinicalTrials.gov Hide glossary (...) Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal

2011 Clinical Trials

119. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia (Abstract)

Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia Topical lidocaine (LDC) treatment using a gel or patch preparation is effective in the treatment of postherpetic neuralgia (PHN), but neither is suited for the eye in patients with ophthalmic PHN. Herein, we examined the effect of LDC 4% eye drops on ophthalmic PHN pain.Twenty-four patients with ophthalmic PHN were randomized to receive 0.4 mL eye drops of either LDC 4% or saline placebo (PBO) in the painful

2010 EvidenceUpdates Controlled trial quality: uncertain

120. [Topical anesthesia before vascular access in children. Comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaine-prilocaine patch]. (Abstract)

[Topical anesthesia before vascular access in children. Comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaine-prilocaine patch]. Venepuncture is one of the most stressful situations for children during induction of general anesthesia. Therefore, many clinicians use a local anesthesia patch (EMLA) containing a mixture of lidocaine and prilocaine in order to reduce the stress for pediatric patients. This study compared the effect of a new heated topical anesthesia delivery (...) system containing lidocaine and tetracaine (Rapydan) with the lidocaine/prilocaine patch EMLA.The study design was prospective, randomized, single-blinded and monocenter. A total of 200 children aged from 3 to 13 years were randomized into group E (EMLA) or group R (Rapydan). The primary endpoint of the study was the overall incidence of pain. Additionally, the intensity of pain during venous puncture was evaluated by means of an investigator-based 4 point pain score: 0 no reaction, 1 gentle movement

2010 Der Anaesthesist Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>